Josh Arnold Investment Consultant LLC raised its position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) by 73.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 52,000 shares of the biotechnology company’s stock after acquiring an additional 22,000 shares during the period. Atara Biotherapeutics makes up about […]